Journal article
Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials
Abstract
BACKGROUND: The safety of long-acting beta(2)-agonists (LABAs) in asthma is debated. This study examined the safety of the inhaled corticosteroid (ICS)/LABA combination budesonide/formoterol dry powder inhaler used as maintenance and reliever therapy versus combination treatments based on guideline recommendations.
METHODS: Safety data from six double-blind, randomised clinical trials (RCTs) in asthma where budesonide/formoterol was used as …
Authors
Sears MR; Radner F
Journal
Respiratory Medicine, Vol. 103, No. 12, pp. 1960–1968
Publisher
Elsevier
Publication Date
December 2009
DOI
10.1016/j.rmed.2009.08.007
ISSN
0954-6111